β1-integrin and BMP4 expression in BM and spleen. (A) Prominent labeling of endothelial cells and hematopoietic cells, including megakaryocytes, is seen in the normal tibia using anti-β1, but labeling of only endothelial cells is seen (B) in β1Δ/Δ tibia. (C) Labeling of endothelial cells and megakaryocytes with 9EG7 antibody (reacting with activated β1) in normal tibia. (D) Labeling only of endothelial cells in β1Δ/Δ tibia. (E) Splenic sections from normal mice after PHZ labeled for F4/80 (diaminobenzidine method) for macrophages and counterstained with hematoxylin. Note the abundance of small dark nuclei (erythroid cells). (F) Splenic sections from β1Δ/Δ mice after PHZ. Fewer erythroid cells together with many unengaged macrophages. (G) Splenic sections from normal mice labeled with 9EG7 antibody (activated β1). Prominent labeling of endothelial cells is seen. (H) Splenic sections from β1Δ/Δ mice similarly labeled with 9EG7. (I) BMP4 labeling of normal spleen after PHZ (day 6) and (J) of β1Δ/Δ spleen. Note the intense labeling of red pulp in both types of spleens. Fluorescent images shown in panels A-D and panels I-J were visualized with Alexa 594, mounted with Vectashield Mounting Medium with 4,6-diamidino-2-phenylindole (Vector Labs) and acquired at room temperature using a Leica DMLB fluorescence microscope (with appropriate filters) and a Spot RT Slider camera using SPOT Advanced software (Version 4.6, Diagnostic Instruments). (E-H) Visualized with diaminobenzidine and hematoxylin were taken at room temperature using an Olympus BH-2 microscope outfitted with a Nikon Coolpix 995 digital camera. Magnification bars are inserted. Some adjustments for brightness, contrast, and color balance using Adobe Photoshop were made.